158 related articles for article (PubMed ID: 38252391)
1. Evaluating Provider and Pharmacy Discordance in Potential Calcium Channel Blocker-Loop Diuretic Prescribing Cascade.
Ndai AM; Morris EJ; Winterstein AG; Vouri SM
Drugs Aging; 2024 Feb; 41(2):177-186. PubMed ID: 38252391
[TBL] [Abstract][Full Text] [Related]
2. Magnitude of and Characteristics Associated With the Treatment of Calcium Channel Blocker-Induced Lower-Extremity Edema With Loop Diuretics.
Vouri SM; Jiang X; Manini TM; Solberg LM; Pepine C; Malone DC; Winterstein AG
JAMA Netw Open; 2019 Dec; 2(12):e1918425. PubMed ID: 31880802
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of a Common Prescribing Cascade of Calcium Channel Blockers and Diuretics in Older Adults With Hypertension.
Savage RD; Visentin JD; Bronskill SE; Wang X; Gruneir A; Giannakeas V; Guan J; Lam K; Luke MJ; Read SH; Stall NM; Wu W; Zhu L; Rochon PA; McCarthy LM
JAMA Intern Med; 2020 May; 180(5):643-651. PubMed ID: 32091538
[TBL] [Abstract][Full Text] [Related]
4. Differences in Health-Related Quality of Life Among Adults with a Potential Dihydropyridine Calcium Channel Blocker-Loop Diuretic Prescribing Cascade.
Morris EJ; Brown JD; Manini TM; Vouri SM
Drugs Aging; 2021 Jul; 38(7):625-632. PubMed ID: 34095980
[TBL] [Abstract][Full Text] [Related]
5. Outcomes of Hospitalized COVID-19 Patients Receiving Renin Angiotensin System Blockers and Calcium Channel Blockers.
Choksi TT; Zhang H; Chen T; Malhotra N
Am J Nephrol; 2021; 52(3):250-260. PubMed ID: 33827074
[TBL] [Abstract][Full Text] [Related]
6. Analysis of Dual Combination Therapies Used in Treatment of Hypertension in a Multinational Cohort.
Lu Y; Van Zandt M; Liu Y; Li J; Wang X; Chen Y; Chen Z; Cho J; Dorajoo SR; Feng M; Hsu MH; Hsu JC; Iqbal U; Jonnagaddala J; Li YC; Liaw ST; Lim HS; Ngiam KY; Nguyen PA; Park RW; Pratt N; Reich C; Rhee SY; Sathappan SMK; Shin SJ; Tan HX; You SC; Zhang X; Krumholz HM; Suchard MA; Xu H
JAMA Netw Open; 2022 Mar; 5(3):e223877. PubMed ID: 35323951
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the key prescription sequence symmetry analysis assumption using the calcium channel blocker: Loop diuretic prescribing cascade.
Vouri SM; Morris EJ; Usmani SA; Reise R; Jiang X; Pepine CJ; Manini TM; Malone DC; Winterstein AG
Pharmacoepidemiol Drug Saf; 2022 Jan; 31(1):72-81. PubMed ID: 34553438
[TBL] [Abstract][Full Text] [Related]
8. An evaluation of a potential calcium channel blocker-lower-extremity edema-loop diuretic prescribing cascade.
Vouri SM; van Tuyl JS; Olsen MA; Xian H; Schootman M
J Am Pharm Assoc (2003); 2018; 58(5):534-539.e4. PubMed ID: 30033126
[TBL] [Abstract][Full Text] [Related]
9. Renin-Angiotensin-Aldosterone System-based Antihypertensive Agents and the Risk of Colorectal Cancer Among Medicare Beneficiaries.
Htoo PT; Stürmer T; Jonsson-Funk M; Pate V; Simpson RJ; Lund JL
Epidemiology; 2019 Nov; 30(6):867-875. PubMed ID: 31348009
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of a Beta-Blocker-Edema-Loop Diuretic Prescribing Cascade: A Prescription Sequence Symmetry Analysis.
Vouri SM; Morris EJ; Jiang X; Hofer AK; Schmidt S; Pepine C; Winterstein AG; Smith SM
Am J Hypertens; 2022 Jul; 35(7):601-609. PubMed ID: 35106529
[TBL] [Abstract][Full Text] [Related]
11. Diuretic or Beta-Blocker for Hypertensive Patients Already Receiving ACEI/ARB and Calcium Channel Blocker.
Tsai MS; Tang CH; Lin CY; Chuang PY; Chen NC; Huang CH; Chang WT; Wang TD; Yu PH; Chen WJ
Cardiovasc Drugs Ther; 2017 Dec; 31(5-6):535-543. PubMed ID: 29218625
[TBL] [Abstract][Full Text] [Related]
12. Renoprotective Effect of the Combination of Renin-angiotensin System Inhibitor and Calcium Channel Blocker in Patients with Hypertension and Chronic Kidney Disease.
Huang RS; Cheng YM; Zeng XX; Kim S; Fu P
Chin Med J (Engl); 2016 Mar; 129(5):562-9. PubMed ID: 26904991
[TBL] [Abstract][Full Text] [Related]
13. First line drug treatment for hypertension and reductions in blood pressure according to age and ethnicity: cohort study in UK primary care.
Sinnott SJ; Douglas IJ; Smeeth L; Williamson E; Tomlinson LA
BMJ; 2020 Nov; 371():m4080. PubMed ID: 33208355
[TBL] [Abstract][Full Text] [Related]
14. Association of Race/Ethnicity-Specific Changes in Antihypertensive Medication Classes Initiated Among Medicare Beneficiaries With the Eighth Joint National Committee Panel Member Report.
Colvin CL; King JB; Oparil S; Wright JT; Ogedegbe G; Mohanty A; Hardy ST; Huang L; Hess R; Muntner P; Bress A
JAMA Netw Open; 2020 Nov; 3(11):e2025127. PubMed ID: 33206191
[TBL] [Abstract][Full Text] [Related]
15. Development and Validation of a Medication Selection Model Under Clinical Application of Renin-Angiotensin Inhibitor Combined with Calcium Channel Blocker for Hypertension Patients.
Hong D; Shi W; Lu X; Lou Y; Li L
Med Sci Monit; 2020 Apr; 26():e923696. PubMed ID: 32285846
[TBL] [Abstract][Full Text] [Related]
16. Renoprotective effects of renin-angiotensin system inhibitor combined with calcium channel blocker or diuretic in hypertensive patients: A PRISMA-compliant meta-analysis.
Cheng Y; Huang R; Kim S; Zhao Y; Li Y; Fu P
Medicine (Baltimore); 2016 Jul; 95(28):e4167. PubMed ID: 27428210
[TBL] [Abstract][Full Text] [Related]
17. Identifying prescribing cascades in Alzheimer's disease and related dementias: The calcium channel blocker-diuretic prescribing cascade.
Singh S; Cocoros NM; Haynes K; Nair VP; Harkins TP; Rochon PA; Platt R; Dashevsky I; Reynolds J; Mazor KM; Bloomstone S; Anzuoni K; Crawford SL; Gurwitz JH
Pharmacoepidemiol Drug Saf; 2021 Aug; 30(8):1066-1073. PubMed ID: 33715299
[TBL] [Abstract][Full Text] [Related]
18. Renin-angiotensin-aldosterone system inhibitors and SARS-CoV-2 infection: an analysis from the veteran's affairs healthcare system.
Sandhu AT; Kohsaka S; Lin S; Woo CY; Goldstein MK; Heidenreich PA
Am Heart J; 2021 Oct; 240():46-57. PubMed ID: 34126079
[TBL] [Abstract][Full Text] [Related]
19. Association of a calcium channel blocker and diuretic prescribing cascade with adverse events: A population-based cohort study.
Rochon PA; Austin PC; Normand SL; Savage RD; Read SH; McCarthy LM; Giannakeas V; Wu W; Strauss R; Wang X; Chen S; Gurwitz JH
J Am Geriatr Soc; 2024 Feb; 72(2):467-478. PubMed ID: 38009803
[TBL] [Abstract][Full Text] [Related]
20. [Assessment of antihypertensive monotherapies effectiveness by home blood pressure self-measurement in hypertensive patients].
Hanon O; Laroche P; Vidal JS; Pannier B; Postel-Vinay N; Vaisse B; Girerd X
Ann Cardiol Angeiol (Paris); 2012 Jun; 61(3):218-23. PubMed ID: 22695025
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
